Abstract. Optical computed tomography ͑optical-CT͒ and optical emission computed tomography ͑optical-ECT͒ are new techniques that enable unprecedented high-resolution 3-D multimodal imaging of tissue structure and function. Applications include imaging macroscopic gene expression and microvasculature structure in unsectioned biological specimens up to 8 cm 3 . A key requisite for these imaging techniques is effective sample preparation including optical clearing, which enables light transport through the sample while preserving the signal ͑either light absorbing stain or fluorescent proteins͒ in representative form. We review recent developments in optical-CT and optical-ECT, and compatible "fluorescence-friendly" optical clearing protocols.
Introduction
The ability to image co-registered biological structure and function in three dimensions in whole unsectioned tissue specimens is of significant present interest. In cancer research, for example, new antiangiogenic agents have potential to enhance the therapeutic effects of principal cancer treatments such as radiation and chemotherapy. 1, 2 There is a need for greater understanding of the complex relationships governing the response of the global microvasculature to these agents to help development of more effective therapies. [3] [4] [5] These efforts have been hampered by the lack of a truly 3-D imaging modality with sufficiently high spatial resolution and contrast to determine subtle microvasculature detail. Such a modality would facilitate study of the vascular response to new therapeutic agents, to variations in fractionation of application, 6, 7 the restructuring of vasculature networks, 8 and the distribution of functional response to hypoxia. 9, 10 Imaging fine microvascular structure presents a challenge to existing imaging techniques, including micro-CT ͑micro-computed tomography͒ and micro-MRI ͑micro-magnetic resonance imaging͒ due to the combined requirement for high contrast and high spatial resolution. Similarly, there is great interest in techniques that can image the efficacy of drug and gene delivery techniques, gene expression, and the genetic response of tumors to therapy. [11] [12] [13] [14] Optical responses to these challenges are now feasible with the development of fluorescent reporter genes ͓e.g., red and green fluorescent proteins ͑RFP/GFP͒, respectively͔ and targeted fluorophors 15, 16 ͓e.g., FITC fluorescin conjugated lectin͔. Confocal and two-photon imaging methods have been applied to obtain some 3-D data, but these methods are limited to a few hundred micrometers depth from the imaging surface. 17, 18 Three-dimensional optical-computed-tomography ͑optical-CT͒ and optical-emission-computed-tomography ͑optical-ECT͒, when combined with optical clearing techniques, can yield high-contrast and high-resolution 3-D images of microvasculature and/or any fluorescent moiety. They represent powerful new techniques for investigating structural, functional, and genetic therapeutic responses and relationships. 19 In previous work optical-CT has been developed in the context of high resolution 3-D dosimetry for verification of radiation therapy treatments. [20] [21] [22] [23] Later, the technique was extended to include emission tomography, and applications were explored in developmental embryology and embryonic gene expression. 24, 25 Recently, a novel implementation was presented 26 along with initial applications imaging xenograft tumors 27 and whole unsectioned rodent organs. In this paper,
we review recent developments in optical-CT and optical-ECT techniques and compatible clearing protocols 28 and illustrate their application with an in-house benchtop imaging system ͑Fig. 1͒.
Basic Principles of the Optical-CT and Optical-ECT Techniques
Optical-CT can be conceived as the optical analog of x-ray CT. Three-dimensional images of the distribution of optical attenuation throughout a sample are reconstructed from optical projection images of light transmitted through the sample. Optical-ECT is the optical analog of SPECT ͑single-photon emission tomography͒. In optical-ECT, 3D images of the distribution of emitting light sources ͑e.g., fluorochromes͒ are reconstructed from emission images of light emitted from the sample. Some of the established benefits associated with combining image data from complimentary modalities, such as x-ray-CT/SPECT or x-ray-CT/PET ͑positron emission tomography͒, translate over to the optical-CT/optical-ECT combination. These include the facility for accurate registration of transmission and emission image data and the potential for relating tissue structure and function, as demonstrated here in relation to xenograft tumor imaging.
Imaging Hardware and Acquisition
Optical projection/emission images are acquired of a sample suspended in ͑for example͒ an agarose gel, mounted vertically on a rotating platform inside a small aquarium made from antireflection-coated glass. The gel rotates inside a highrefractive-index matched fluid, which minimizes refraction, enabling straight-line projection/emission images to be acquired. In optical-CT ͑transmission mode͒ light from a uniform back-light traverses through the sample to image formation at the CCD. Projections are acquired in a "step-andimage" manner at small angular increments ͑e.g., 0.3 deg͒ through a complete 360-deg revolution. In optical-ECT ͑emis-sion mode͒ excitation light causes longer wavelength fluorescent light to be emitted within the sample, which is then also imaged on the CCD, as illustrated. The use of telecentric lenses in the optical imaging system facilitates accurate optical-CT and optical-ECT images, as image formation occurs from light traveling parallel to the optic axis. Acquisition proceeds in the same step-and-image procedure, with the same settings and constraints as already described. A key difference is that narrow-bandwidth optical filters are used to select both the excitation and emitting wavelengths. Highquality filters greatly enhance effective image quality by reducing any contaminant autofluorescence. A DSRed2 filter set was used to select for the excitation and emission wavelengths corresponding to RFP ͑558 and 583 nm, respectively͒. Exposure of the sample to excitation light was minimized by utilization of a shutter, which permitted exposure only during image acquisition. Consistent interprojection normalization was achieved by keeping the exposure time constant for each projection. Once a complete set of projection or emission images has been acquired, 3-D reconstructions of the sample were created using the commercial COBRA Feldkamp filtered backprojection algorithm ͑Exxim Computing Corp, Pleasantown, California͒. Input parameters were adjusted to reflect the geometries of the image acquisition. In principle, the spatial resolution can approach the resolution of the CCD camera as the resolution of the lens is usually far higher. In practice, however, resolution is lost through the tomographic reconstruction and artifacts arising from motion point spread function and projection noise. Present prototype systems have been reported to have a modulation transfer function ͑MTF͒ ϳ10% at 20 lp/ mm, but substantial improvements are expected. The microoptical-CT scanner presented in Fig. 1 represents a second-generation and very fast scanning system when compared with the first-generation optical-CT devices described elsewhere. [20] [21] [22] 29, 30 The time for a typical acquisition of 360 projections was about 5 min.
Optical Clearing for Optical-CT and Optical-ECT
A significant difference between the optical and x-ray imaging analogs is that the poor optical transmission of biological tissue necessitates ex vivo sample preparation to improve optical transmission ͑the optical clearing process͒. Despite this limitation, accurate "in vivo" functional information is entirely feasible because optical stains and fluorescing labels can be applied in vivo, such that representative staining/labeling is achieved for subsequent imaging. Meaningful imaging of any functional parameter therefore requires preservation of the condition of that stain/label through the excision and sample preparation procedures. Optical clearing can be achieved by dehydration and reperfusion of the tissue with a transparent solution of high refractive index close to that of the cell nuclear and organelle membranes. In general, better- Fig. 1 Schematic of light paths through a prototype optical-CT ͑a͒ and optical-ECT ͑b͒ imaging system. In optical-CT, light from a uniform backlight traverses through the sample to form projection images captured by a CCD camera. In optical-ECT, incident light orthogonal to the imaging axis stimulates fluorescence in the sample. In both modes, a telecentric lens is used to form an image dominated by light parallel to the optic axis, thereby best approximating the parallel ray geometry and minimizing scatter contamination. ͑Based on Oldham et al.
reconstructed image quality ͑both optical-CT and optical-ECT͒ is directly associated with better optical clearing, provided the signal of interest ͑here isotonic-ink in the vasculature, and fluorescent proteins͒ are not affected by the optical clearing process. Illustrative projection images through various unsectioned tissue samples that were cleared and labeled using the processes described later are shown in Fig. 2͑a͒ . The images were acquired using the system shown in Fig. 1͑a͒ , with a backlight source of wavelength 633 nm. Corresponding transmission characteristics of the samples relative to methyl-salicylate are shown in Fig. 2͑b͒ . All samples were imaged immersed in methyl salicylate. The lowest transmission was observed for the rat heart because of the high concentration of ink taken up in the vasculature and ventricle chambers. The highest transmission is observed in the brain, where ink uptake was greatly reduced due to the blood brain barrier.
General sample preparation
All samples were whole ͑i.e., unsectioned͒ at the time of imaging and optically cleared to enable visible light penetration through the sample. The principle of optical clearing is to replace the water-based cellular fluid with a solution of high refractive index to match that of the cell, nuclear, and organelle membranes. 31, 32 Achieving quality optical clearing is a key step that enables the feasibility of both optical-CT and optical-ECT. All tissue samples imaged in this paper were first set in 0.75% agarose gel by weight. The tissue samples were positioned centrally and ϳ1 cm up from the bottom of the gel. Staining and fixing procedures varied between samples, and details are discussed in the corresponding following sections. The purpose of the agarose gel was to stabilize the sample during rotation incurred in the optical-CT/optical-ECT acquisition. Each sample ͑agarose and imbedded tissue͒ was then immersed in a succession of graded ethanol/water solutions, until the tissue was completely dehydrated. Once the sample was fully permeated with 100% ethanol, they were then immersed in a succession of graded ethanol with methylsalicylate or benzyl-alcohol benzyl benzoate ͑BABBs͒, until the ethanol was completely replaced by the higher refractive index liquid. The large pore size of agarose gel facilitates efficient fluid exchange. Methyl salicylate was used for clearing any tissue sample containing fluorescent proteins, as better fluorescent preservation has been observed. For nonfluorescent samples, optical clearing was achieved with BABBs solution, which leads to slightly better optical clarity. These are the only clearing solutions we have tested so far but, in principle, any transparent solution with high refractive index ͑ϳ1.54͒ that can be perfused into tissue can be a viable clearing agent. The solutions have negligible influence on the physical size and shape of organ. Furthermore, hematoxylinand-eosin ͑H&E͒ histological evaluation of cleared specimens are virtually indistinguishable from control noncleared specimens. However, we have been unsuccessful so far in achieving immunohistological staining on tissue samples that have been optically cleared in this way.
"Fluorescence-friendly" optical clearing
Oldham et al. 27 investigated the feasibility of 3-D imaging the viable tumor burden in HCT116 tumor xenografts. The HCT116 cell line had been transfected with a gene coding for constitutively expressed 33 RFP. Viable tumor cells therefore express red fluorescence when exposed to the excitation wavelength. The initial challenge was to develop a tissue optical-clearing procedure that would preserve RFP fluorescence in the cleared tissue. A series of plating experiments were performed, where the transfected HCT116 tumor cells were exposed to a variety of tissue-fixing and clearing agents representing different potential clearing processes. Full details of the clearing procedures are given in Ref. 28 . The effect on RFP and GFP fluorescence is shown in Fig. 3 . The significant result from these experiments is that substantial fluorescence preservation was achieved when the initial cell fixation was in ethanol. Fixation in either PFA or methanol resulted in almost complete loss of fluorescence ͓Figs. 3͑A͒ and 3͑B͔͒. Furthermore, after ethanol fixation, the cells proved robust to subsequent exposure to either clearing agent BABBs or MetSal. To successfully image RFP in whole xeneograft tumors, the results of the plating experiments must be transferred to whole tumor specimens. This was achieved by first performing Fig. 2 ͑a͒ Light transmission projection images of a variety of optically cleared unsectioned tissue samples, acquired using the imaging system illustrated in Fig. 1͑a͒ , with a backlight of wavelength 633 nm and ͑b͒ light absorbtion characteristics of these samples acquired with a spectrophotometer, relative to pure methyl salicylate.
perfusion-fixation of the tumors in situ, by aortic cannulation and gravitational drip feed of ethanol. Tumors were then placed in ethanol at 4°C overnight, and set in 0.75% agarose the next day. The clearing procedure involved perfusion graded solutions of water:ethanol, and then ethanol:methylsalicylate. The total clearing process for tissue samples of order 1 cm 3 typically takes from 1 to 3 weeks, depending on size of sample, under gentle motion-assisted diffusion processes at room temperature. A similar procedure was used irrespective of the particular agent used for dehydration and clearing steps. The sample is initially placed in a 75:25 ethanol:water solution, which is changed to 100% ethanol after 12 h, and then refreshed on a daily basis for 4 days. Complete dehydration is necessary to avoid precipitation of opaque regions of agarose, which may occur if water and clearing agent react with agarose gel. The sample is then placed in a 50:50 solution of ethanol:clearing agent. After 24 h, the solution is changed to 100% clearing agent, which is also replenished on a daily basis.
Application of Optical-CT and Optical-ECT

Imaging Xenograft Tumors
Oldham et al. 27 presented preliminary data imaging HCT116RFP xenograft colon cancer tumors, containing constitutive RFP labeling, grown on the hind legs of nude mice, following the procedures of an Institutional Animal Care and Use Committee ͑IACUC͒ approved protocol. When the tumors had grown to a ϳ1 cm length, labeling/staining of the tumor microvasculature was achieved by tail vein injection and subsequent natural circulation around the body of a double bolus of isotonic india ink and fluorescent probe ͑lec-tin conjugated with FITC͒. The carbon-based ink particles circulate in the blood stream and are phagocytosed inside endothelial cells of the vessels, thereby marking patent microvasculature. 34 At 5 to 10 min postinfusion, the mouse was sacrificed and the tumor removed for sample preparation. Lectin actively binds to endothelial cells of the microvasculature, providing independent labeling of the microvasculature amenable for optical-ECT imaging. The implementation of both passive and active labeling of microvasculature enables cross-validation and comparison of both techniques. A single optical transmission or projection image of the whole HCT116 tumor is shown in Fig. 4͑A͒ , and contrasted with micro-x-ray-CT and micro-MRI images acquired with state of the art small animal imaging systems 35, 36 ͓Figs. 4͑B͒ and 4͑C͔͒ to highlight the excellent contrast and resolution of optical-CT. Exquisite visualization of the microvasculature was observed in the optical projection, although the 3-D nature of the vascular network is lost. In this instance, the vasculature is primarily seen on the periphery of the tumor, with a few larger vessels penetrating to the tumor core. As these tumors were implanted subcutaneously, especially dense and intensive vasculature is seen along one side of the tumor where it was attached to the underlying fascia of the animal.
Quantitative information is available from CT reconstructions of the projections. Figures 5͑A͒-5͑C͒ show such a reconstruction from 240 projections acquired at 1.5-deg increments. The original projection images ͑1040ϫ 1388 pixels͒ were downsized to 748ϫ 998 ͑to match present software restrictions͒ and reconstructed on a 512ϫ 512ϫ 512 grid. The pixel dimensions in the image are thus ϳ30 m, although a greater number of projections must be acquired to meet the Nyquist criteria for this resolution limit. Significant vascular penetration is observed to be limited to the lower part of the tumor ͓Fig. 5͑B͔͒, indicating this region was relatively well perfused. The corresponding reconstructions of the emitting FITC distribution within the tumor, acquired with the FITC filters, are shown in Figs. 5͑D͒-5͑F͒ . In general, a clear correlation and agreement is observed between the optical-CT and optical-ECT images. Well-perfused regions appear bright in the optical-CT images ͑corresponding to regions high ink absorption͒ and also as bright regions in the optical-ECT images ͑where the scale is inverted such that light pixel values correspond to high emission of light and hence high concentration of FITC͒. The HCT116 tumor was also imaged in optical-ECT mode with DSRed2 filter set ͓Figs. 5͑G͒ to 5͑H͔͒. This image is significant as it represents the 3-D distribution of RFP emitted by viable tumor cells. The correlations between the corresponding views in Fig. 5 are striking, and clearly show that regions of high RFP expression correlate closely with the well-perfused regions. This makes intuitive sense, as one would expect the more viable regions of the tumor to correlate with perfusion. A precise interpretation is complex due to the novelty of these techniques, and requires reference to more established imaging modalities. Further interpretation of the optical-ECT images would require an attenuation correction, similar to that routinely encountered in SPECT imaging. Comparison with conventional histological sections ͓Fig. 5͑J͔͒ provided strong supporting evidence for the conclusions derived above from the optical imaging modalities. The peripheral band of well-perfused viable cells, inferred from all three optical reconstructions ͓Figs. 5͑B͒, 5͑E͒, and 5͑H͔͒ exhibits strong H&E staining in histological section ͑Fig. 5͑J͒͒ and therefore viable cells in this region. The large central areas devoid of vasculature and viable cells, as determined from the optical modalities, are indeed found to be devoid of H&E stain, indicating regions of necrosis.
The images shown in Fig. 5 were acquired with a prototype microscope-based optical system that incorporated nontelecentric optical components with limited suitability for tomographic imaging due primarily to limited depth of field. More recent images of similar tumors acquired with the bench system of Fig. 1 are shown in Fig. 6 . A significant improvement in image quality is observed, through the removal of artifacts associated with the limited depth of field of the microscope system. Figure 6 also presents the first reconstructions of endogenous gene expression in three dimensions in xenograft tumors using optical-ECT. This was achieved using FITC filter sets and an HCT116 cell line that was double labeled with reporter proteins. Constitutive RFP-labeled viable tumor ͑as in the preceding͒, but secondary GFP labeling was incorporated to report the expression of the HIF1 gene. 33 While further work ͑for example, development of an attenuation correction for optical-ECT͒ and independent validation are required to fully understand the interpretation of these images, the potential utility is evident.
Whole Rodent Organ Imaging
Vascular staining in rodent organs was achieved by tail vein injection of isotonic ink as described in Sec. 3.1. Organs were prepared for optical-CT imaging using the procedure outlined in Sec. 2.1. Reconstructed images of a rat heart and lung are shown in Figs. 7 and 8, respectively. Postimaging histological study of these samples confirmed that the lighter regions in these images correspond to tissues with higher optical attenuation ͑greater ink staining͒, and higher perfusion. 26 In the heart images, the most prominent features are the coronary arteries, ventricles, and other areas of high blood content. Excellent detail of general heart structure is also observed. Similar observations are made in the lung images of Fig. 8 . The major and minor bronchial airways are clearly visible, as are interesting variations in perfusion around the lung.
Discussion and Conclusions
Optical-CT and optical-ECT are relatively new imaging modalities that, when combined with optical clearing techniques, can provide unique 3-D information in high resolution and high contrast on the structure and function ͑including gene expression͒ of tissue. The optical clearing techniques reviewed here were developed from earlier techniques developed to clear thin sections of tissue for optical microscopy. A significant step forward was the development of clearing protocols that preserve the fluorescence output of unsectioned bulk tissue samples. 28 As with any new imaging modality, accurate interpretation of image content is gradually established by reference and correlation to alternative more established methodologies. The bulk of this effort has yet to be accomplished. Here, we reviewed the physical basis and demonstrated preliminary application to imaging xenograft tumor microvasculature and, for the first time, preliminary 3-D images showing endogenous gene expression in xenograft tumors ͑HIF1 expression͒, and whole rodent organs. The true potential of these techniques may be even wider, as it should be feasible to image a wide range of other tumor and normal tissue structures and functions, depending on the development of corresponding optical probes.
